Back to search

France· FR:61106121

SULFATE DE MAGNESIUM LAVOISIER 15 POUR CENT (0,15 g/ml), solution injectable (I.V.) en ampoule

A medicinal product containing sulfate de magnésium heptahydraté, registered in France by LABORATOIRES CHAIX ET DU MARAIS.

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedSULFATE DE MAGNESIUM LAVOISIER 15 POU…ATC—REGISTER NO.FR:61106121PACKS LISTED4CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
SULFATE DE MAGNÉSIUM HEPTAHYDRATÉ
Manufacturer
LABORATOIRES CHAIX ET DU MARAIS
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 4

  • cip13
    3400936299801
    10 ampoule(s) bouteille en verre de 10 ml
  • cip13
    3400936299979
    10 ampoule(s) bouteille en verre de 20 ml
  • cip13
    3400955026600
    100 ampoule(s) polypropylène de 10 ml
  • cip13
    3400956478125
    100 ampoule(s) bouteille en verre de 10 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sulfate de magnésium heptahydraté in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sulfate de magnésium heptahydraté products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Denmark · Magnesiumsulfat Sad
  • United Kingdom (Northern Ireland) · Magnesium Sulphate Phoenix Labs
  • Greece · Magnesium Sulfate Ariti
  • Ireland · Magnesium Sulfate Foran Healthcare
  • Netherlands · Magnesiiumsulfaat Teva, Magnesiumsulfaat Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/afb0b147-b9ea-4ef9-86d8-4d7b3f5689d5
GET /v1/drugs/afb0b147-b9ea-4ef9-86d8-4d7b3f5689d5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61106121",
  "date_amm": "1998-08-04",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "SULFATE DE MAGNÉSIUM HEPTAHYDRATÉ",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about sulfate de magnésium heptahydraté.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.